Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2011 (2011), Article ID 728103, 10 pages
http://dx.doi.org/10.4061/2011/728103
Review Article

Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection

Division of Surgery, Depatments of Hepatobiliary Pancreatic Surgery and Artificial Organ and Transplantation, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Received 15 February 2011; Revised 16 April 2011; Accepted 24 April 2011

Academic Editor: Daisuke Morioka

Copyright © 2011 Yoji Kishi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Llovet, J. Fuster, and J. Bruix, “Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation,” Hepatology, vol. 30, no. 6, pp. 1434–1440, 1999. View at Google Scholar · View at Scopus
  2. J. Bruix, M. Sherman, J. M. Llovet et al., “Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver,” Journal of Hepatology, vol. 35, no. 3, pp. 421–430, 2001. View at Google Scholar
  3. J. M. Llovet, C. Brú, and J. Bruix, “Prognosis of hepatocellular carcinoma: the BCLC staging classification,” Seminars in Liver Disease, vol. 19, no. 3, pp. 329–337, 1999. View at Google Scholar
  4. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. T. Ishizawa, K. Hasegawa, T. Aoki et al., “Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma,” Gastroenterology, vol. 134, no. 7, pp. 1908–1916, 2008. View at Publisher · View at Google Scholar · View at PubMed
  6. L. Capussotti, A. Ferrero, L. Viganò, R. Polastri, and M. Tabone, “Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines,” European Journal of Surgical Oncology, vol. 35, no. 1, pp. 11–15, 2009. View at Publisher · View at Google Scholar · View at PubMed
  7. S. T. Fan, C. M. Lo, C. L. Liu et al., “Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths,” The Annals of Surgery, vol. 229, no. 3, pp. 322–330, 1999. View at Google Scholar
  8. H. Imamura, Y. Seyama, N. Kokudo et al., “One thousand fifty-six hepatectomies without mortality in 8 years,” Archives of Surgery, vol. 138, no. 11, pp. 1198–1206, 2003. View at Publisher · View at Google Scholar · View at PubMed
  9. Japan LCSGo, General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Kenehara, Tokyo, Japan, 2003.
  10. M. Makuuchi, N. Kokudo, S. Arii et al., “Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan,” Hepatology Research, vol. 38, no. 1, pp. 37–51, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. G. T. Huang, P. O. H. Lee, Y. M. Tsang et al., “Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study,” The Annals of Surgery, vol. 242, no. 1, pp. 36–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Chen, J. Q. Li, Y. Zheng et al., “A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma,” The Annals of Surgery, vol. 243, no. 3, pp. 321–328, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. K. Hasegawa, N. Kokudo, and M. Makuuchi, “Surgery or ablation for hepatocellular carcinoma?” The Annals of surgery, vol. 247, no. 3, pp. 557–558, 2008. View at Google Scholar · View at Scopus
  14. V. Mazzaferro, E. Regalia, R. Doci et al., “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” The New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. Huang, L. Yan, Z. Cheng et al., “A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria,” The Annals of Surgery, vol. 252, no. 6, pp. 903–912, 2010. View at Google Scholar
  16. M. Makuuchi, B. L. Thai, K. Takayasu et al., “Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report,” Surgery, vol. 107, no. 5, pp. 521–527, 1990. View at Google Scholar · View at Scopus
  17. M. Palavecino, Y. S. Chun, D. C. Madoff et al., “Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival,” Surgery, vol. 145, no. 4, pp. 399–405, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. T. Aoki, H. Imamura, K. Hasegawa et al., “Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma,” Archives of Surgery, vol. 139, no. 7, pp. 766–774, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Ogata, J. Belghiti, O. Farges, D. Varma, A. Sibert, and V. Vilgrain, “Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma,” British Journal of Surgery, vol. 93, no. 9, pp. 1091–1098, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. S. Hwang, S. G. Lee, G. I. Y. Ko et al., “Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy,” The Annals of Surgery, vol. 249, no. 4, pp. 608–616, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. N. H. Lee, G. Y. Chau, W. Y. Lui, K. L. King, S. H. Tsay, and C. W. Wu, “Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter,” British Journal of Surgery, vol. 85, no. 12, pp. 1654–1657, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. T. P. Poon, S. T. Fan, and J. Wong, “Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter,” The Journal of the American College of Surgeons, vol. 194, no. 5, pp. 592–602, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. K. H. Liau, L. Ruo, J. Shia et al., “Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma,” Cancer, vol. 104, no. 9, pp. 1948–1955, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. D. Pandey, K. H. Lee, C. T. Wai, G. Wagholikar, and K. C. Tan, “Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2817–2823, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. V. Paradis, S. Zalinski, E. Chelbi et al., “Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis,” The Journal of Hepatology, vol. 49, no. 3, pp. 851–859, 2009. View at Google Scholar
  26. “Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver cancer study group of Japan,” Cancer, vol. 74, no. 10, pp. 2772–2780, 1994.
  27. J. N. Vauthey, D. Klimstra, D. Franceschi, Y. Tao, J. Fortner, and L. Blumgart, “Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma,” The American Journal of Surgical Pathology, vol. 169, no. 1, pp. 28–34, 1995. View at Google Scholar
  28. M. Kanda, R. Tateishi, H. Yoshida et al., “Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors,” Liver International, vol. 28, no. 9, pp. 1256–1263, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. M. Llovet, J. Bustamante, A. Castells et al., “Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials,” Hepatology, vol. 29, no. 1, pp. 62–67, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. T. M. Pawlik, R. T. Poon, E. K. Abdalla et al., “Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study,” Surgery, vol. 137, no. 4, pp. 403–410, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Shi, E. C. H. Lai, N. Li et al., “Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus,” Annals of Surgical Oncology, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. D. X. Lin, Q. Y. Zhang, X. Li, Q. W. Ye, F. Lin, and L. L. Li, “An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus,” Journal of Cancer Research and Clinical Oncology, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. C. C. Wu, S. R. Hsieh, J. T. Chen et al., “An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation,” Archives of Surgery, vol. 135, no. 11, pp. 1273–1279, 2000. View at Google Scholar · View at Scopus
  34. M. Minagawa, M. Makuuchi, T. Takayama, and K. Ohtomo, “Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus,” The Annals of Surgery, vol. 233, no. 3, pp. 379–384, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Ikai, E. Hatano, S. Hasegawa et al., “Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein,” The Journal of the American College of Surgeons, vol. 202, no. 3, pp. 431–438, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. Y. P. Le Treut, J. Hardwigsen, P. Ananian et al., “Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. a European case-control series,” The Journal of Gastrointestinal Surgery, vol. 10, no. 6, pp. 855–862, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. Y. Inoue, K. Hasegawa, T. Ishizawa et al., “Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?” Surgery, vol. 145, no. 1, pp. 9–19, 2009. View at Google Scholar
  38. D. Ban, K. Shimada, Y. Yamamoto et al., “Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein,” The Journal of Gastrointestinal Surgery, vol. 13, no. 11, pp. 1921–1928, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. S. Satoh, I. Ikai, G. Honda et al., “Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi,” Surgery, vol. 128, no. 5, pp. 779–783, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. T. Noda, H. Nagano, Y. Tomimaru et al., “Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery,” Surgery, vol. 149, no. 3, pp. 371–377, 2011. View at Google Scholar
  41. N. Ikenaga, K. Chijiiwa, K. Otani, J. Ohuchida, S. Uchiyama, and K. Kondo, “Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion,” The Journal of Gastrointestinal Surgery, vol. 13, no. 3, pp. 492–497, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. T. P. Poon, S. T. Fan, C. B. O'Suilleabhain, and J. Wong, “Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy,” The Journal of the American College of Surgeons, vol. 195, no. 3, pp. 311–318, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Yang, H. Nagano, and H. Ota, “Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection,” Surgery, vol. 141, no. 2, pp. 196–202, 2007. View at Google Scholar
  44. S. Katyal, J. H. Oliver III, M. S. Peterson, J. V. Ferris, B. S. Carr, and R. L. Baron, “Extrahepatic metastases of hepatocellular carcinoma,” Radiology, vol. 216, no. 3, pp. 698–703, 2000. View at Google Scholar · View at Scopus
  45. M. Natsuizaka, T. Omura, T. Akaike et al., “Clinical features of hepatocellular carcinoma with extrahepatic metastases,” The Journal of Gastroenterology and Hepatology, vol. 20, no. 11, pp. 1781–1787, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. Y. Tomimaru, Y. O. Sasaki, T. Yamada et al., “The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma,” The American Journal of Surgery, vol. 192, no. 1, pp. 46–51, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. S. W. Kuo, Y. L. Chang, P. M. Huang et al., “Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 992–997, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. K. Norimasa, K. Haruhiko, S. Kenji, A. Hisao, S. Kazuaki, and T. Ryosuke, “Surgical treatment of pulmonary metastasis from hepatocellular carcinoma,” Hepato-Gastroenterology, vol. 54, no. 73, pp. 152–156, 2007. View at Google Scholar · View at Scopus
  49. M. Kawamura, J. Nakajima, H. Matsuguma et al., “Surgical outcomes for pulmonary metastases from hepatocellular carcinoma,” European Journal of Cardio-Thoracic Surgery, vol. 34, no. 1, pp. 196–199, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. K. M. Chan, M. C. Yu, T. J. Wu et al., “Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 15, no. 43, pp. 5481–5488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Sakamoto, K. Kubota, M. Mori et al., “Surgical management for adrenal gland metastasis of hepatocellular carcinoma,” Hepato-Gastroenterology, vol. 46, no. 26, pp. 1036–1041, 1999. View at Google Scholar · View at Scopus
  52. M. Makuuchi, H. Hasegawa, and S. Yamazaki, “Ultrasonically guided subsegmentectomy,” Surgery Gynecology & Obstetrics, vol. 161, no. 4, pp. 346–350, 1985. View at Google Scholar · View at Scopus
  53. H. Imamura, Y. Matsuyama, Y. Miyagawa et al., “Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma,” The British Journal of Surgery, vol. 86, no. 8, pp. 1032–1038, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. M. Yamamoto, K. Takasaki, T. Ohtsubo, H. Katsuragawa, C. Fukuda, and S. Katagiri, “Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis,” Surgery, vol. 130, no. 3, pp. 443–448, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. K. Hasegawa, N. Kokudo, H. Imamura et al., “Prognostic impact of anatomic resection for hepatocellular carcinoma,” The Annals of Surgery, vol. 242, no. 2, pp. 252–259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Eguchi, T. Kanematsu, S. Arii et al., “Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey,” Surgery, vol. 143, no. 4, pp. 469–475, 2008. View at Google Scholar
  57. T. Kamiyama, K. Nakanishi, H. Yokoo, H. Kamachi, M. Matsushita, and S. Todo, “The impact of anatomical resection for hepatocellular carcinoma that meets the Milan criteria,” The Journal of Surgical Oncology, vol. 101, no. 1, pp. 54–60, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. S. Arii, K. Teramoto, T. Kawamura et al., “Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience,” The Journal of Hepato-Biliary-Pancreatic Surgery, vol. 8, no. 5, pp. 397–403, 2001. View at Google Scholar · View at Scopus
  59. M. Shimada, K. Takenaka, T. Gion et al., “Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan,” Gastroenterology, vol. 111, no. 3, pp. 720–726, 1996. View at Google Scholar · View at Scopus
  60. R. T. P. Poon, S. T. Fan, C. M. Lo, C. L. Liu, and J. Wong, “Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors,” The Annals of Surgery, vol. 229, no. 2, pp. 216–222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Nakajima, S. Ko, T. Kanamura et al., “Repeat liver resection for hepatocellular carcinoma,” The Journal of the American College of Surgeons, vol. 192, no. 3, pp. 339–344, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Sugimachi, S. Maehara, S. Tanaka, M. Shimada, and K. Sugimachi, “Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma,” The Journal of Hepato-Biliary-Pancreatic Surgery, vol. 8, no. 5, pp. 410–416, 2001. View at Google Scholar · View at Scopus
  63. T. Itamoto, H. Nakahara, H. Amano et al., “Repeat hepatectomy for recurrent hepatocellular carcinoma,” Surgery, vol. 141, no. 5, pp. 589–597, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. C. C. Wu, S. B. Cheng, D. C. Yeh, J. Wang, and F. K. P'eng, “Second and third hepatectomies for recurrent hepatocellular carcinoma are justified,” British Journal of Surgery, vol. 96, no. 9, pp. 1049–1057, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. M. Minagawa, M. Makuuchi, T. Takayama, and N. Kokudo, “Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma,” The Annals of Surgery, vol. 238, no. 5, pp. 703–710, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. R. T. P. Poon, H. Ngan, C. M. Lo, C. L. Liu, S. T. Fan, and J. Wong, “Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence,” Journal of Surgical Oncology, vol. 73, no. 2, pp. 109–114, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Yang, M. H. Chen, and S. S. Yin, “Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence,” AJR. American Journal of Roentgenology, vol. 185, supplement 5, pp. S275–S283, 2006. View at Google Scholar
  68. K. Taura, I. Ikai, E. Hatano, H. Fujii, N. Uyama, and Y. Shimahara, “Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old,” The Annals of Surgery, vol. 244, no. 2, pp. 265–273, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. D. Choi, H. K. Lim, H. Rhim et al., “Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors,” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2319–2329, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. Y. Okuwaki, T. Nakazawa, S. Kokubu et al., “Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma,” The American Journal of Gastroenterology, vol. 104, no. 11, pp. 2747–2753, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. N. Portolani, G. L. Baiocchi, A. Coniglio et al., “Sequential multidisciplinary treatment of hepatocellular carcinoma: the role of surgery as rescue therapy for failure of percutaneous ablation therapies,” The Journal of Surgical Oncology, vol. 100, no. 7, pp. 580–584, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. R. Adam, V. Delvart, G. Pascal et al., “Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival,” The Annals of Surgery, vol. 240, no. 4, pp. 644–658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. B. Nordlinger, H. Sorbye, B. Glimelius et al., “Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial,” The Lancet, vol. 371, no. 9617, pp. 1007–1016, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. R. Adam, D. A. Wicherts, R. J. de Haas et al., “Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?” The Journal of Clinical Oncology, vol. 26, no. 10, pp. 1635–1641, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. D. G. Blazer, Y. Kishi, D. M. Maru et al., “Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases,” The Journal of Clinical Oncology, vol. 26, no. 33, pp. 5344–5351, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. S. Yamasaki, H. Hasegawa, H. Kinoshita et al., “A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma,” Japanese Journal of Cancer Research, vol. 87, no. 2, pp. 206–211, 1996. View at Google Scholar · View at Scopus
  77. T. Harada, K. Matsuo, T. Inoue, S. Tamesue, T. Inoue, and H. Nakamura, “Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?” The Annals of Surgery, vol. 224, no. 1, pp. 4–9, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. G. E. Gerunda, D. Neri, R. Merenda et al., “Role of transarterial chemoembolization before liver resection for hepatocarcinoma,” Liver Transplantation, vol. 6, no. 5, pp. 619–626, 2000. View at Google Scholar · View at Scopus
  79. A. Sasaki, Y. Iwashita, K. Shibata, M. Ohta, S. Kitano, and M. Mori, “Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma,” European Journal of Surgical Oncology, vol. 37, no. 7, pp. 773–779, 2006. View at Google Scholar
  80. G. I. H. Choi, D. H. Kim, C. M. Kang et al., “Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?” World Journal of Surgery, vol. 31, no. 12, pp. 2370–2377, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. W. P. Zhou, E. C. H. Lai, A. J. Li et al., “A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma,” The Annals of Surgery, vol. 249, no. 2, pp. 195–202, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. K. T. Lee, Y. W. Lu, S. N. Wang et al., “The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes,” The Journal of Surgical Oncology, vol. 99, no. 6, pp. 343–350, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. C. C. Wu, Y. Z. Ho, W. L. Ho, T. C. Wu, T. J. Liu, and F. K. P'Eng, “Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal,” British Journal of Surgery, vol. 82, no. 1, pp. 122–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  84. X. P. Chen, D. Y. Hu, Z. W. Zhang et al., “Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma,” Digestive Surgery, vol. 24, no. 3, pp. 208–213, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. I. S. Kim, Y. S. Lim, H. C. Lee, D. J. Suh, Y. J. Lee, and S. G. Lee, “Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome,” Alimentary Pharmacology and Therapeutics, vol. 27, no. 4, pp. 338–345, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. E. Adachi, T. Matsumata, T. Nishizaki, H. Hashimoto, M. Tsuneyoshi, and K. Sugimachi, “Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma: the relationship between postoperative course and tumor necrosis,” Cancer, vol. 72, no. 12, pp. 3593–3598, 1993. View at Publisher · View at Google Scholar · View at Scopus
  87. O. Matsui, M. Kadoya, J. Yoshikawa et al., “Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization,” Radiology, vol. 188, no. 1, pp. 79–83, 1993. View at Google Scholar · View at Scopus
  88. M. Uchida, H. Kohno, H. Kubota et al., “Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma,” World Journal of Surgery, vol. 20, no. 3, pp. 326–331, 1996. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Sugo, S. Futagawa, T. Beppu, M. Fukasawa, and K. Kojima, “Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence,” World Journal of Surgery, vol. 27, no. 12, pp. 1295–1299, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. M. Kaibori, N. Tanigawa, Y. Matsui et al., “Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction,” Anticancer Research, vol. 26, no. 5, pp. 3685–3692, 2006. View at Google Scholar · View at Scopus
  91. J. Fan, Z. Y. Tang, Y. Q. Yu et al., “Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma,” Digestive Surgery, vol. 15, no. 6, pp. 674–678, 1998. View at Google Scholar · View at Scopus
  92. R. Izumi, K. Shimizu, T. Iyobe et al., “Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma,” Hepatology, vol. 20, no. 2, pp. 295–301, 1994. View at Publisher · View at Google Scholar · View at Scopus
  93. B. G. Peng, Q. He, J. P. Li, and F. Zhou, “Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus,” The American Journal of Surgery, vol. 198, no. 3, pp. 313–318, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. J. M. Llovet, S. Ricci, V. Mazzaferro et al., “Sorafenib in advanced hepatocellular carcinoma,” The New England Journal of Medicine, vol. 359, no. 4, pp. 378–390, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. W. Y. Lau, T. W. Leung, B. S. Lai et al., “Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma,” The Annals of Surgery, vol. 233, no. 2, pp. 236–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. W. Y. Lau, S. K. Ho, S. C. Yu, E. C. Lai, C. T. Liew, and T. W. Leung, “Salvage surgery following downstaging of unresectable hepatocellular carcinoma,” The Annals of Surgery, vol. 240, no. 2, pp. 299–305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. L. M. Kulik, B. Atassi, L. Van Holsbeeck et al., “Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation,” The Journal of Surgical Oncology, vol. 94, no. 7, pp. 572–586, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. S. Obi, H. Yoshida, R. Toune et al., “Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion,” Cancer, vol. 106, no. 9, pp. 1990–1997, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. H. Nagano, A. Miyamoto, and H. Wada, “Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules,” Cancer, vol. 110, no. 11, pp. 2493–2501, 2007. View at Google Scholar
  100. L. M. Kulik, B. I. Carr, M. F. Mulcahy et al., “Safety and efficacy of Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis,” Hepatology, vol. 47, no. 1, pp. 71–81, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. M. R. M. Gagner and J. Dubuc, “Laparoscopic partial hepatectomy for liver tumor [Abstract].,” Surgical Endoscopy, vol. 6, p. 99, 1992. View at Google Scholar
  102. K. T. Nguyen, T. C. Gamblin, and D. A. Geller, “World review of laparoscopic liver resection-2,804 patients,” The Annals of Surgery, vol. 250, no. 5, pp. 831–841, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. A. J. Koffron, G. Auffenberg, and R. Kung, “Evaluation of 300 minimally invasive liver resections at a single institution: less is more,” The Annals of Surgery, vol. 246, no. 3, pp. 385–392, 2007. View at Google Scholar
  104. A. M. Kazaryan, I. P. Marangos, A. R. Rosseland et al., “Laparoscopic liver resection for malignant and benign lesions: ten-year Norwegian single-center experience,” Archives of Surgery, vol. 145, no. 1, pp. 34–40, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. I. Dagher, G. Belli, C. Fantini et al., “Laparoscopic hepatectomy for hepatocellular carcinoma: a european experience,” The Journal of the American College of Surgeons, vol. 211, no. 1, pp. 16–23, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. J. Y. Cho, H. S. Han, Y. S. Yoon, and S.H Shin, “Feasibility of laparoscopic liver resection for tumors located in the posterosuperior segments of the liver, with a special reference to overcoming current limitations on tumor location,” Surgery, vol. 144, no. 1, pp. 32–38, 144. View at Google Scholar
  107. Y. S. Yoon, H. S. Han, J. Y. Cho, and K. S. Ahn, “Total laparoscopic liver resection for hepatocellular carcinoma located in all segments of the liver,” Surgical Endoscopy, vol. 24, no. 7, pp. 1630–1637, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. J. F. Buell, D. Cherqui, and D. A. Geller, “The international position on laparoscopic liver surgery: the louisville statement,” The Annals of Surgery, vol. 250, no. 5, pp. 825–830, 2009. View at Google Scholar
  109. A. Laurent, D. Cherqui, and M. Lesurtel, “Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease,” Archives of Surgery, vol. 138, no. 7, pp. 763–769, 2003. View at Google Scholar
  110. N. O'Rourke and G. Fielding, “Laparoscopic right hepatectomy: surgical technique,” Journal of Gastrointestinal Surgery, vol. 8, no. 2, pp. 213–216, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. G. Belli, C. Fantini, A. D'Agostino et al., “Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results,” Surgical Endoscopy, vol. 21, no. 11, pp. 2004–2011, 2007. View at Google Scholar
  112. H Kaneko, M. Tsuchiya, Y. Otsuka et al., “Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 16, no. 4, pp. 433–438, 2009. View at Google Scholar
  113. J. F. Buell, M. T. Thomas, S. Rudich et al., “Experience with more than 500 minimally invasive hepatic procedures,” The Annals of Surgery, vol. 248, no. 3, pp. 475–485, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. L. Vigano, A. Laurent, C. Tayar, M. Tomatis, A. Ponti, and D. Cherqui, “The learning curve in laparoscopic liver resection: improved feasibility and reproducibility,” The Annals of Surgery, vol. 250, no. 5, pp. 772–780, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. S. Todo and H. Furukawa, “Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan,” The Annals of Surgery, vol. 240, no. 3, pp. 451–459, (2004). View at Google Scholar
  116. S. Hwang, S. G. Lee, J. W. Joh, K. S. Suh, and D. G. Kim, “Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations,” Liver Transplantation, vol. 11, no. 10, pp. 1265–1272, 2005. View at Google Scholar
  117. http://www.unos.org.
  118. F. Y. Yao, L. Ferrell, N. M. Bass et al., “Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival,” Hepatology, vol. 33, no. 6, pp. 1394–1403, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. J. Y. Leung, A. X. Zhu, F. D. Gordon et al., “Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study,” Liver Transplantation, vol. 10, no. 11, pp. 1343–1354, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. J. P. Duffy, A. Vardanian, E. Benjamin et al., “Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA,” The Annals of Surgery, vol. 246, no. 3, pp. 502–509, 2007. View at Google Scholar
  121. Y. Sugawara, S. Tamura, and M. Makuuchi, “Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series,” Digestive Diseases, vol. 25, no. 4, pp. 310–312, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. Y. Soejima, A. Taketomi, T. Yoshizumi et al., “Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma,” Transplantation, vol. 83, no. 7, pp. 893–899, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  123. T. Ito, Y. Takada, M. Ueda et al., “Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation,” Liver Transplantation, vol. 13, no. 12, pp. 1637–1644, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. A. Taketomi, K. Sanefuji, Y. Soejima et al., “Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation,” Transplantation, vol. 87, no. 4, pp. 531–537, 2009. View at Google Scholar
  125. M. Berenguer, L. Ferrell, J. Watson et al., “HCV-related fibrosis progression following liver transplantation: increase in recent years,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 32, no. 4, pp. 673–684, 2000. View at Google Scholar
  126. L. Lladó, J. Fabregat, J. Castellote et al., “Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study,” Liver Transplantation, vol. 14, no. 12, pp. 1752–1760, 2008. View at Google Scholar
  127. N. Weiler, I. Thrun, M. Hoppe-Lotichius, T. Zimmermann, I. Kraemer, and G. Otto, “Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial,” Transplantation, vol. 90, no. 12, pp. 1562–1566, 2010. View at Google Scholar
  128. Y. Sugawara, J. Kaneko, and M. Makuuchi, “Cyclosporin a for treatment of hepatitis C virus after liver transplantation,” Transplantation, vol. 82, no. 4, pp. 579–580, 2006. View at Google Scholar
  129. Y. Sugawara, M. Makuuchi, Y. Matsui, N. Akamatsu, J. Kaneko, and N. Kokudo, “Preemptive therapy for hepatitis C virus after living-donor liver transplantation,” Transplantation, vol. 78, no. 9, pp. 1308–1311, 2004. View at Google Scholar
  130. S. Tamura, Y. Sugawara, N. Yamashiki, J. Kaneko, N. Kokudo, and M. Makuuchi, “Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: Observation based on a single-center experience,” Transplant International, vol. 23, no. 6, pp. 580–588, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. J. Belghiti, A. Cortes, and E. K. Abdalla, “Resection prior to liver transplantation for hepatocellular carcinoma,” The Annals of Surgery, vol. 238, no. 6, pp. 885–892, 2003. View at Google Scholar
  132. C. Margarit, A. Escartín, L. Castells, V. Vargas, E. Allende, and I. Bilbao, “Resection for hepatocellular carcinoma is a good option in Child-turcotte-pugh class a patients with cirrhosis who are eligible for liver transplantation,” Liver Transplantation, vol. 11, no. 10, pp. 1242–1251, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. P. Majno, G Mentha, and V. Mazzaferro, “Resection, transplantation, either, or both? Other pieces of the puzzle,” Liver Transplantation, vol. 11, no. 10, pp. 1177–1180, 2005. View at Google Scholar
  134. D. Cherqui, A. Laurent, N. Mocellin et al., “Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation,” The Annals of Surgery, vol. 250, no. 5, pp. 738–745, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  135. Y. Takada, M. Ueda, T. Ito et al., “Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma,” Liver Transplantation, vol. 12, no. 6, pp. 912–919, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus